Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 136 Records) |
Query Trace: MOS[original query] |
---|
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. American journal of hematology 2023 9 . Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koji Sasaki, Kelly S Chien, Danielle Hammond, Guillermo Montalban-Bravo, Gautam Borthakur, Nicholas Short, Ghayas C Issa, Tapan M Kadia, Naval Daver, Guilin Tang, Andres Quesada, Keyur P Patel, Farhad Ravandi, Warren Fiskus, Cristopher P Mill, Hagop M Kantarjian, Kapil Bhalla, Guillermo Garcia-Manero, Betul Oran, Courtney D DiNar |
Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia. BMC genomics 2023 9 24 (1): 542. Clinton O Onyango, Qiuying Cheng, Elly O Munde, Evans Raballah, Samuel B Anyona, Benjamin H McMahon, Christophe G Lambert, Patrick O Onyango, Kristan A Schneider, Douglas J Perkins, Collins Ou |
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study. Thoracic cancer 2023 9 . Yangchun Gu, Jinyu Yu, Haifeng Hu, Hua Zhang, Baoshan Cao, Li Lia |
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas B Karasic, Charles Schneider, Erica L Carpenter, Katherine Nathanson, Susan M Domchek, Kim A Rei |
Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors. JTO clinical and research reports 2023 7 4 (6): 100524. Ryo Ariyasu, Sho Kakuto, Keiki Miyadera, Takahiro Akita, Ayu Kiritani, Ryosuke Tsugitomi, Yoshiaki Amino, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Makoto Nish |
KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry. Clinical lung cancer 2023 6 . Johan Isaksson, Anders Berglund, Karly Louie, Linda Willén, Arash Hamidian, Anders Edsjö, Fredrik Enlund, Maria Planck, Anders Vikström, Mikael Johansson, Andreas Hallqvist, Gunnar Wagenius, Johan Botli |
Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China. Advances in therapy 2023 6 . Xinhua Zhang, Peng Zhang, Haibo Qiu, Yong Fang, Heli Liu, Yongjian Zhou, Hao Xu, JiRen Yu, Jun Zhang, Ming Wang, Lin Shen, Jian |
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study. Targeted oncology 2023 6 . Hélène Babey, Philippe Jamme, Hubert Curcio, Jean Baptiste Assié, Remi Veillon, Hélène Doubre, Maurice Pérol, Florian Guisier, Eric Huchot, Chantal Decroisette, Lionel Falchero, Romain Corre, Alexis Cortot, Christos Chouaïd, Renaud Descou |
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers 2023 6 15 (11): . Vincenzo Formica, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Emanuela Dell'Aquila, Marta Schirripa, Marco Messina, Lisa Salvatore, Federica Lo Prinzi, Giovanni Dima, Giovanni Trovato, Silvia Riondino, Mario Roselli, Ferdinandos Skoulidis, Hendrik-Tobias Arkenau, Chiara Cremoli |
Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations. Thoracic cancer 2023 4 . Zhang Ling, You Yunhong, Liu Xueli, Liu Fengjuan, Nie Keke, Ji Youx |
[Genetic analysis of a Fra(16)(q22) fragile site in a female with secondary infertility]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 495-499. Xie Chengxiu, Gao Chonglan, Kang Han, Liu Qingso |
Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer. Cureus 2023 2 15 (1): e33916. Miranda Baleiras Mafalda, Dias Domingues Tiago, Severino Eduardo, Vasques Carolina, Neves Maria Teresa, Ferreira André, Vasconcelos de Matos Leonor, Ferreira Filipa, Miranda Helena, Martins A |
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes. Clinical lymphoma, myeloma & leukemia 2023 2 . Tinsley-Vance Sara M, Ali Najla Al, Ball Somedeb, Aguirre Luis E, Jain Akriti G, Hussaini Mohammad Omar, Chan Onyee, Kuykendall Andrew, Sweet Kendra, Lancet Jeffrey, Padron Eric, Sallman David A, Komrokji Rami |
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C. Digestive diseases and sciences 2023 2 1-9. Bonkovsky Herbert L, Rudnick Sean P, Ma Christopher D, Overbey Jessica R, Wang Kelly, Faust Denise, Hallberg Csilla, Hedstrom Karli, Naik Hetanshi, Moghe Akshata, Anderson Karl |
Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study. Cancer medicine 2023 11 . Jingyi Guo, Qun Zhou, Mingzhen Zhou, Hengheng Dai, Lin Li, Yudong Qiu, Liang Mao, Baorui Liu, Jie Sh |
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group. Haematologica 2023 11 . Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Selim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joel Fleury, Fabrice Jardin, Clementine Sarkozy, Ghandi Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cecile Chabrot, Veronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Reda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morineau, Marie Pierre Moles, Hacene Zerazhi, Jean Fontan, Yazid Arkam, Magda Alexis, Vincent Delwail, Jean Pierre Vilque, Loic Ysebaert, Barbara Burroni, Mary Callanan, Steven Le Gouill, Rémy Gress |
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations. BMC pulmonary medicine 2023 11 23 (1): 482. Xiaoling Shang, Wengang Zhang, Wenfei Han, Handai Xia, Ni Liu, Xiuwen Wang, Yanguo L |
Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
[Genetic analysis of a fetus with mosaicism Y chromosome aberration]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 10 40 (11): 1414-1419. Fanrong Meng, Duan Ju, Xiuyan Wang, Yunfang Shi, Meng Yang, Xiaozhou |
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 2023 1 15 (1): . Peleg Hasson Shira, Hershkovitz Dov, Adar Lyri, Brezis Miriam, Shachar Eliya, Aks Rona, Galmor Lee, Raviv Yuval, Ben Neriah Shira, Merimsky Ofer, Sabo Edmond, Wolf Ido, Safra Tam |
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients. Targeted oncology 2023 1 18 (1): 139-145. Rimini Margherita, Fabregat-Franco Carles, Persano Mara, Burgio Valentina, Bergamo Francesca, Niger Monica, Scartozzi Mario, Rapposelli Ilario Giovanni, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Casadei-Gardini Andr |
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study. Translational lung cancer research 2023 1 11 (12): 2539-2566. Xiao Zhiwei, Sun Lingling, Zheng Yating, Chen Hanrui, Zheng Xinting, Luo Jiamin, Gu Chuying, Lin Ruiting, Huang Mengli, Bai Yuezong, Chen Zhe-Sheng, Kinslow Connor J, Loh Jerold, Lin Liz |
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast cancer research and treatment 2024 1 . Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping |
Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances 2024 1 . Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lanc |
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China. Frontiers in oncology 2024 1 13 1300199. Jinghong Chen, Mengpei Zhang, Kemin Li, Yuanqiong Duan, Xiaojuan Lin, Lan Zhong, Qintong Li, Rutie Y |
Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. Frontiers in genetics 2024 1 14 1320789. Tonia Carter, Robert K Valenzuela, Srinivasulu Yerukala Sathipati, Rafael Medina-Flor |
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. Clinical & translational immunology 2024 1 13 (1): e1483. Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, Chen Xu, Lin Li, Baorui Liu, Jie Sh |
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer. Clinical lung cancer 2024 1 . Laurent Mathiot, Benoit Nigen, Thomas Goronflot, Sandrine Hiret, Ludovic Doucet, Elvire Pons-Tostivint, Jaafar Bennouna, Marc G Denis, Guillaume Herbreteau, Judith Raimbou |
Correlation analysis of EGFR gene mutation abundance and the efficacy of targeted therapy with osimertinib in nonsmall cell lung cancer-a case control study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2024 1 10781552231224372. Haiqiang Yan, Jigui Peng, Wang Zhou, Hui Chen, Changjin |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: